» Articles » PMID: 28655813

Neurovascular Unit Protection From Cerebral Ischemia-Reperfusion Injury by Radical-Containing Nanoparticles in Mice

Abstract

Background And Purpose: Reperfusion therapy by mechanical thrombectomy is used to treat acute ischemic stroke. However, reactive oxygen species generation after reperfusion therapy causes cerebral ischemia-reperfusion injury, which aggravates cerebral infarction. There is limited evidence for clinical efficacy in stroke for antioxidants. Here, we developed a novel core-shell type nanoparticle containing 4-amino-4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (nitroxide radical-containing nanoparticles [RNPs]) and investigated its ability to scavenge reactive oxygen species and confer neuroprotection.

Methods: C57BL/6J mice underwent transient middle cerebral artery occlusion and then received RNPs (9 mg/kg) through the common carotid artery. Infarction size, neurological scale, and blood-brain barrier damage were visualized by Evans blue extravasation 24 hours after reperfusion. RNP distribution was detected by rhodamine labeling. Blood-brain barrier damage, neuronal apoptosis, and oxidative neuronal cell damage were evaluated in ischemic brains. Multiple free radical-scavenging capacities were analyzed by an electron paramagnetic resonance-based method.

Results: RNPs were detected in endothelial cells and around neuronal cells in the ischemic lesion. Infarction size, neurological scale, and Evans blue extravasation were significantly lower after RNP treatment. RNP treatment preserved the endothelium and endothelial tight junctions in the ischemic brain; neuronal apoptosis, O production, and gene oxidation were significantly suppressed. Reactive oxygen species scavenging capacities against OH, ROO, and O improved by RNP treatment.

Conclusions: An intra-arterial RNP injection after cerebral ischemia-reperfusion injury reduced blood-brain barrier damage and infarction volume by improving multiple reactive oxygen species scavenging capacities. Therefore, RNPs can provide neurovascular unit protection.

Citing Articles

Bioactive Materials Facilitate the Restoration of Neurological Function Post Cerebral Ischemic Stroke.

Wang C, Sun C, Ding Z, Wu X, Liu K, Cao J Int J Nanomedicine. 2025; 19:14171-14191.

PMID: 39764188 PMC: 11701096. DOI: 10.2147/IJN.S493987.


Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system.

Liu W, Liu L, Li H, Xie Y, Bai J, Guan J J Nanobiotechnology. 2024; 22(1):499.

PMID: 39164747 PMC: 11337765. DOI: 10.1186/s12951-024-02772-2.


Long non-coding RNA SNHG12 regulates leptomeningeal collateral remodeling via RGMa after ischemic stroke.

Jiang A, Wang Z, Cheng R, Zhang S, Wu Q, Qin X Neurotherapeutics. 2024; 21(5):e00429.

PMID: 39138027 PMC: 11579872. DOI: 10.1016/j.neurot.2024.e00429.


Design of Antioxidant Nanoparticle, which Selectively Locates and Scavenges Reactive Oxygen Species in the Gastrointestinal Tract, Increasing The Running Time of Mice.

Toriumi T, Ohmori H, Nagasaki Y Adv Sci (Weinh). 2023; 10(27):e2301159.

PMID: 37526346 PMC: 10520625. DOI: 10.1002/advs.202301159.


Efficacy of redox nanoparticles for improving survival of transplanted cells in a mouse model of ischemic stroke.

Hirata K, Marushima A, Nagasaki Y, Ishikawa H, Matsumura H, Mujagic A Hum Cell. 2023; 36(5):1703-1715.

PMID: 37418231 DOI: 10.1007/s13577-023-00940-4.